Form 4 for PMVP PMV Pharmaceuticals, Inc.
Accepted 2023-11-13 00:00:00 ET · period of report 2023-10-18 · accession 0001209191-23-054997 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-13 | 2023-11-10 | PMVP | Mack David Henry | Pres, CEO, Dir | G - Gift | $0.00 | -85.3K | 278.6K | -23% | $0 |
| D | 2023-11-13 | 2023-10-18 | PMVP | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.53 | +198.4K | 363.9K | +120% | +$105.2K |
| DI | 2023-11-13 | 2023-11-10 | PMVP | Mack David Henry | Pres, CEO, Dir | G - Gift | $0.00 | +85.3K | 165.3K | +107% | $0 |
| D | 2023-11-13 | 2023-08-07 | PMVP | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.00 | -198.4K | 109.5K | -64% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-10 | G | D | 85,307 | $0.00 | 278,570 | D | — | — | |
| 2 | Common | Common Stock | 2023-10-18 | M | A | 198,407 | $0.53 | 363,877 | D See footnote | — | — | (F1) The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein. |
| 3 | Common | Common Stock | 2023-11-10 | G | A | 85,307 | $0.00 | 165,307 | I | — | — | |
| 4 | Derivative | Employee Stock Option (right to buy) | 2023-08-07 | M | D | 198,407 | $0.00 | 109,459 | D | $0.53 · — to 2025-05-11 | 198,407 Common Stock | (F4) The shares subject to the option are fully vested and immediately exercisable. |